potassium bicarbonate (Effer-K, K-lyte)

Indications

• hypokalemia
• hypokalemia associated with metabolic acidosis & hyperchloremia

Dosage

Tablet: 25 meq with citric acid.

Pharmacokinetics

• elimination :route kidney

Adverse effects

• hyperkalemia
• GI irritation

More general terms

• salt
• metabolic agent (metabolic modifier)

Additional terms

• K+

Component of

• pancreatin/potassium bicarbonate/sodium bicarbonate
• citrate/potassium bicarbonate/sodium bicarbonate

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=61102
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=516893